2023
DOI: 10.3390/ph16091198
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, DFT Study, and In Vitro Evaluation of Antioxidant Properties and Cytotoxic and Cytoprotective Effects of New Hydrazones on SH-SY5Y Neuroblastoma Cell Lines

Diana Tzankova,
Hristina Kuteva,
Emilio Mateev
et al.

Abstract: A series of ten new hydrazide–hydrazone derivatives bearing a pyrrole ring were synthesized and structurally elucidated through appropriate spectral characteristics. The target hydrazones were assessed for radical scavenging activity through 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) tests, with ethyl 5-(4-bromophenyl)-1-(2-(2-(4-hydroxy-3,5-dimethoxybenzylidene)hydrazine-yl)-2-oxoethyl)-2-methyl-1H-pyrrole-3-carboxylate (7d) and ethyl 5-(4-bromophen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 49 publications
0
3
0
Order By: Relevance
“…experimental conditions allowing evaluation of these properties are a promising rejection of the least drug-like molecule prior to progression into the lead-discove in order to justify a drug discovery effort. Some of our preliminary experiments with compounds possessing a centra ring and a hydrazide-hydrazone fragment pointed our attention to their promisin in neurodegeneration therapy research [12][13][14]. This determined as most scien interesting the structure of compound 11b, presented in Figure 1 and show multiple points of biotransformation related to molecules based on an Nhydrazide-hydrazone moiety.…”
Section: Selection Of the Target Hydrazone 11bmentioning
confidence: 97%
“…experimental conditions allowing evaluation of these properties are a promising rejection of the least drug-like molecule prior to progression into the lead-discove in order to justify a drug discovery effort. Some of our preliminary experiments with compounds possessing a centra ring and a hydrazide-hydrazone fragment pointed our attention to their promisin in neurodegeneration therapy research [12][13][14]. This determined as most scien interesting the structure of compound 11b, presented in Figure 1 and show multiple points of biotransformation related to molecules based on an Nhydrazide-hydrazone moiety.…”
Section: Selection Of the Target Hydrazone 11bmentioning
confidence: 97%
“…Therefore, an initial evaluation toward the CYP450 activity for each active molecule is required in the process of drug development (Manikandan et al 2018). The examined structures were initially synthesized by Tzankova et al 2023. The series MI_a-e and MII_a-e were studied for possible inhibitory effects on some isoforms of Cytochrome P450 -CY-P1A2; CYP2D6, which revealed genetic polymorphism; and CYP3A4, which metabolized over 60 % of the drugs on the market.…”
Section: In Vitro Assaysmentioning
confidence: 99%
“…In the current study, the initial compounds were previously synthesized and evaluated for their DPPH, ABTS and MAO activities (Tzankova et al 2023). The general structure of the pyrrole-based compounds is given in Fig.…”
Section: Introductionmentioning
confidence: 99%